Profile
Alka Batycky served as the Director at Landos Biopharma, Inc. from 2023 to 2024.
Prior to that, she held the position of Vice President-Program & Alliance Management at AMAG Pharmaceuticals, Inc. and Vice President-Portfolio & Alliance Management at Warp Drive Bio, Inc. She also served as the Chief Development Officer at Finch Therapeutics Group, Inc. from 2022 to 2023 and at Ohana Biosciences, Inc. from 2019 to 2021.
Dr. Batycky obtained her undergraduate and doctorate degrees from the University of London.
Former positions of Alka Batycky
| Companies | Position | End |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Director/Board Member | 2024-05-22 |
| FINCH THERAPEUTICS GROUP, INC. | Corporate Officer/Principal | 2023-03-30 |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2021-03-31 |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Alka Batycky
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Commercial Services |
Ohana Biosciences, Inc.
Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Alka Batycky
